By Global Health & Regulatory Desk Published: October 2023 Main Facts As the global medical community braces for a projected 45% surge in new cancer diagnoses in the United States by 2030—escalating from 1.6 million to an alarming 2.3 million cases annually—a sobering question looms over modern medicine: Are we…
By Global Health & Investigative News Desk Published: October 2023 Main Facts The modern oncology landscape is defined by an unsettling paradox: even as pharmaceutical companies flood the market with hundreds of high-tech, patented anticancer agents, the overarching trajectory of the "war on cancer" remains deeply troubling. Projections from epidemiological…
Main Facts: The Crisis in Modern Oncology As the global medical community races to find cures for one of humanity’s most feared afflictions, a disturbing reality has emerged from behind the polished doors of pharmaceutical laboratories and regulatory agencies. The U.S. Food and Drug Administration (FDA)—along with its international counterparts,…
By Global Health & Medical Correspondent Published: October 2023 As the global medical community races to combat one of humanity’s most persistent adversaries, sobering projections indicate that the U.S. cancer burden is set to escalate dramatically. By the year 2030, new cancer diagnoses in the United States are expected to…
Main Facts: The Crisis of Unproven Cancer Therapeutics As the global medical community races to combat one of humanity’s most persistent adversaries, a troubling reality has come to light within oncology pipelines and regulatory frameworks. According to a growing body of peer-reviewed research, a significant majority of chemotherapy drugs approved…
By Penelope Bass July 10, 2026 The ready-to-drink (RTD) beverage sector has long been characterized by a deluge of carbonated hard seltzers, canned cocktails, and hyper-caffeinated energy boosters. In an era where a new SKU hits the virtual shelves of direct-to-consumer platforms and physical retail aisles with dizzying frequency, it…
